Skip to main content
. 2023 May 7;15(5):1427. doi: 10.3390/pharmaceutics15051427
CIT Cancer immunotherapy
ICB Immune checkpoint blockade
CAR Chimeric antigen receptor
CLTA4 Cytotoxic T lymphocyte antigen 4
PD1 Programmed cell death 1
PDL1 Programmed cell death ligand 1
FDA Food and Drug Administration
PTT Photothermal therapy
PDT Photodynamic therapy
ATP Adenosine triphosphate
HMGB-1 High-motility group box 1
CRT Calreticulin
APC Antigen-presenting cell
DC Dendritic cell
NK natural killer
ICD Immunogenic cell death
PEG polyethylene) glycol
ROS Reactive oxygen species
GSH) Glutathione
MMP Matrix metalloproteinase
ZnPcs Zinc phthalocyanine
PLGA polymers polylactic-co-glycolic acid)
TPP Lipophilic triphenylphosphonium
DAMPs Damage-associated molecules
AuNS Gold nanostars
CRC Colorectal Cancer
TSCC Tongue Squamous Cell Carcinoma
NPt-Ca Platinum Acetylacetonate with titania
NIR Near-infrared
TLR Toll-like receptor
pMHC Peptide major histocompatibility complex
IL Interleukin
PEGMA Polyethylene glycol) methacrylate
MPC 2-methacryloyloxyethyl phosphorylcholine
DOX Doxorubicin
LA Lactic acid
LDHA Lactate dehydrogenase A
DCA Dichloroacetate
GOx Glucose oxidase
AQ4N Banoxantrone dihydrochloride
TCA Tricarboxylic acid
CHC α-cyano-4-hydroxycinnamate
γ-Fe2O3 Maghemite
Fe3O4 Magnetite
SPIONs Superparamagnetic iron oxide nanoparticles
MRI Magnetic resonance imaging
MH Magnetic hyperthermia
AMF Alternating magnetic field
MINP Magnetic-responsive immunostimulatory nanoagent
CpG ODNs Cytosine-phosphate-guanine oligodeoxynucleotides
PA Photoacoustic
ZIF-8 Zeolitic imidazolate framework-8
ICG Indocyanine green
OVA Ovalbumin
cpMF Circularly polarized magnetic field
HCSV Hybrid core–shell vesicle
AA Ascorbic acids
IONCs Iron oxide nanocubes
UVB Ultra-violet B
mPEG Methoxy PEG
DSPE 2-distearoyl-sn-glycero-3-phosphoethanolamine